Noonberg Sarah B.

FORMER OFFICER at MGX; Director at PTGX

Sold, on record
$222k
Dollars the filings state
Form 4 sales
2
Latest Jun 6, 2025
Form 144 notices
1
Proposed sales
Companies
2
Filed as an executive or holder

Companies

  • MGXMetagenomi, Inc.FORMER OFFICER
  • PTGXProtagonist Therapeutics, IncDirector

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale PTGXUnusual
    Feb 11, 2021 2021

    Sold 8,400 shares at $25.30 ($213k)

    Noonberg Sarah B., Director

    Sold 100% of holdings ($213k position)0 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale MGXNo plan
    Jun 6, 2025 +1576 days

    Sold 5,239 shares at $1.75 ($9k)

    Noonberg Sarah B., Chief Medical Officer

    No 10b5-1 planSold 4.6% of holdings ($200k position)109,135 shares leftFirst sale on recordFiling

  3. 3 Form 144 notice MGXNotice
    Sep 11, 2025 +97 days

    Filed to sell 35,832 shares ($68k)

    Noonberg Sarah B., FORMER OFFICER

    No 10b5-1 planFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Noonberg Sarah B.
Source
Sep 11, 2025Sep 11, 2025MGXFORMER OFFICERForm 144 notice35,832$68kNoticeSEC
Jun 6, 2025Jun 9, 2025MGXChief Medical OfficerForm 4 sale5,239$9k4.6%No planSEC
Feb 11, 2021Feb 12, 2021PTGXDirectorForm 4 sale8,400$213k100.0%UnusualSEC